Skip to main content
Clinical Trials/IRCT20200722048172N1
IRCT20200722048172N1
Recruiting
Phase 3

Comparison and evaluation of the effectiveness of oral captopril and oral hydrochlorothiazide in the treatment of urgency hypertensive patients

Islamic Azad University0 sites70 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Islamic Azad University
Enrollment
70
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with known hypertension with a blood pressure of 160/90 mm Hg or more and patients with the new\-onset sever hypertention with a blood pressure of 180/110 mm Hg or more without organ damage (urgency) will be included in the study if satisfied.
  • Patients between the ages of 18 and 65 will be included in the study.

Exclusion Criteria

  • Patients who need intravenous drugs to control their blood pressure or other blood pressure medications for different reasons.
  • Patients who need high dose of ACEIs or ARBs (\> 50 mg/d Captopril, \> 10 mg/d Enalapril, \> 5 g/dLisinopril, \> 50 mg/d Losartan, \> 80 mg/d Valsartan),to control their blood pressure.
  • Patients with myocardial infarction presenting with acute chest pain.
  • Patients with severe renal or hepatic failure,anuria, papillaryedema, pulmonary edema, loss of consciousness, seizure,aortic dissection, or bilateral renal artery stenosis; pregnantpatients, patients with a history of overt allergy or angioedemawith ACEIs, Allergy to penicillins and sulfonamides.

Outcomes

Primary Outcomes

Not specified

Similar Trials